SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-QSB

            QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE

                         SECURITIES EXCHANGE ACT OF 1934

                FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2002

                            Commission File #0-30503

                      CONSOLIDATED MEDICAL MANAGEMENT, INC.
             (Exact name of registrant as specified in its charter)

                                     MONTANA
         (State or other jurisdiction of incorporation or organization)

                                   82-0369233
                      (IRS Employer Identification Number)

                7500 San Felipe, Suite 600, Houston, Texas 77063
               (Address of principal executive offices)(Zip Code)

                                  713-914-8138
                (Registrant's telephone no., including area code)

Consolidated Medical Management, Inc., 7500 San Felipe, Suite 600 Houston, Texas
                                     77063,
   (Former name, former address and former fiscal year, if changed since last
                                     report)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes [X] No [ ]

The number of shares outstanding of the Company's common stock as of September
30, 2002 is shown below:

Title of Class                               Number of Shares Outstanding
Common Stock, par value $.001 per share      22,022,293

                   Documents Incorporated by Reference:  None


<PAGE>
                      CONSOLIDATED MEDICAL MANAGEMENT, INC.

                                   FORM 10-QSB

                                Table of Contents

PART I -  FINANCIAL INFORMATION

Item 1 -  Financial Information

Item 2 -  Management's Discussion and Analysis of Financial Condition and
          Results of Operations

Item 3 -  Item 307 of Regulation S-B



PART II - OTHER INFORMATION

Item 2 -  Changes in Securities and Use of Proceeds

Item 6 -  Reports on Form 8-K

SIGNATURES



<PAGE>
PART I - FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

The financial statements of the company are set forth beginning on page F-1.




                      CONSOLIDATED MEDICAL MANAGEMENT, INC.


                            ________________________




              UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
         For the three and nine months ended September 30, 2002 and 2001





                                       F-1
<PAGE>
                      CONSOLIDATED MEDICAL MANAGEMENT, INC.

                                TABLE OF CONTENTS

                             ______________________



                                                                            PAGE
                                                                            ----

Unaudited Consolidated Condensed Financial Statements:

  Unaudited Consolidated Condensed Balance Sheet as of
    September 30, 2002 and December 31, 2001                                 F-3

  Unaudited Consolidated Condensed Statement of Operations
    for the three and nine months ended September 30, 2002
    and 2001                                                                 F-4

    Unaudited Consolidated Condensed Statement of Cash Flows
    for the nine months ended September 30, 2002 and 2001                    F-5

Notes to Unaudited Consolidated Condensed Financial Statements               F-6



                                       F-2
<PAGE>
<TABLE>
<CAPTION>
                          CONSOLIDATED MEDICAL MANAGEMENT, INC.
                                 (A MONTANA CORPORATION)
                                CONSOLIDATED BALANCE SHEET
                                       (UNAUDITED)


                                        ASSETS
                                        ------
                                                                                 SEPT 30, 2002    DECEMBER 31, 2001
                                                                                ---------------  -------------------
<S>                                                                             <C>              <C>

Current Assets
--------------
  Cash                                                                          $        2,030   $            5,470
                                                                                ---------------  -------------------
                                 Total Current Assets                                    2,030                5,470

Non-Current Assets
------------------
  Oil & Gas Properties                                                                  31,107                    -
                                                                                ---------------  -------------------

                                                                                ---------------  -------------------
                                 Total Assets                                   $       33,137   $            5,470
                                                                                ===============  ===================

                     LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
                     ----------------------------------------------

Current Liabilities
-------------------
  Notes Payable-Current Portion                                                         33,367               25,767
  Accounts Payable                                                                     112,980              108,012
  Accrued Expenses                                                                     234,347              196,630
  Convertible Debentures                                                               465,000              465,000
                               and Notes Payable-Current Portion
                                                                                ---------------  -------------------
                                 Total Current Liabilities                             845,694              795,409

  Notes Payable - Long Term Portion                                                     56,867               54,726

                               Long-Term Portion
                                                                                ---------------  -------------------
                                Total Long-Term Liabilities                             56,867               54,726
                                                                                ---------------  -------------------

                                 Total Liabilities                              $      902,561   $          850,135
                                                                                ===============  ===================

Commitments and Contingencies:
------------------------------

Stockholders' Equity
--------------------
Common Stock                                                                    $       17,187   $           13,591

Additional Paid-in-Capital     $0.001 par value, 50,000,000 shares authorized
                               17,187,347 shares issued and outstanding as of        3,967,013            3,553,061
Stock Subscription Receivable  Sept 30, 2002 and 13,587,293 shares issued and         (554,839)            (396,003)
Retained Earnings (Deficit)    outstanding as of December 31, 2001.                 (4,298,785)          (4,015,314)
                                                                                ---------------  -------------------
                                 Total Stockholders' Equity (Deficit)                 (869,424)            (844,665)
                                                                                ---------------  -------------------
                                 Total Liabilities and Stockholders' Equity
                                 (Deficit)                                      $       33,137   $            5,470
                                                                                ===============  ===================
</TABLE>


                                      F-3
<PAGE>
<TABLE>
<CAPTION>
                                       CONSOLIDATED MEDICAL MANAGEMENT, INC.
                                              (A MONTANA CORPORATION)
                                       CONSOLIDATED STATEMENT OF OPERATIONS
                                                    (UNAUDITED)


                                          THREE MONTHS ENDED SEPT 30              NINE MONTHS ENDED SEPT 30,
                                    --------------------------------------  --------------------------------------
                                           2002                2001                2002               2001
                                    ------------------  ------------------  ------------------  ------------------
<S>                                 <C>                 <C>                 <C>                 <C>
Revenues                            $               -   $               -   $               -   $               -
--------

Operating Expenses
  Personnel Costs                                   -                   -              52,736                   -
  Consulting                                        -              41,655             154,000              41,655
  Legal and Professional                       15,055               5,000              25,351              23,800
  Office Expense                                2,258               2,137              13,667               4,479
  Occupancy                                         -                   -                                   1,880
                                    ------------------  ------------------  ------------------  ------------------
  Total Operating Expenses          $          17,313   $          48,792   $         245,754   $          71,814

Income (Loss) from Operations                 (17,313)            (48,792)           (245,754)            (71,814)

Other Income (Expenses)
  Other                                             -                   -                                 528,387
  Interest Expense                            (13,046)            (15,435)            (37,717)            (56,686)
  Interest Income                                   -                   -                                       -
                                    ------------------  ------------------  ------------------  ------------------
                                              (13,046)            (15,435)            (37,717)            471,701

Income (Loss) before Income Taxes   $         (30,359)  $         (64,227)  $        (283,471)  $         399,887

Income Tax Expense                                  -                   -                   -                   -
                                    ------------------  ------------------  ------------------  ------------------
Net Income (Loss)                   $         (30,359)  $         (64,227)  $        (283,471)  $         399,887
                                    ==================  ==================  ==================  ==================
Net Income (Loss) per Share         $               -   $           (0.01)  $           (0.02)  $            0.03
                                    ==================  ==================  ==================  ==================
                                                    -                                       -
</TABLE>


                                      F-4
<PAGE>
<TABLE>
<CAPTION>
                                              CONSOLIDATED MEDICAL MANAGEMENT, INC.
                                               CONSOLIDATED STATEMENT OF CASH FLOWS
                                                           (UNAUDITED)


                                                                       NINE MONTHS ENDED SEPT 30,
                                                                       ----------------------------------------------------------
                                                                       2002                          2001
                                                                       ----------------------------  ----------------------------
<S>                                                                    <C>                           <C>

Cash Flows from Operating Activities:
-------------------------------------
  Net Income (Loss)                                                    $                  (283,471)  $                   399,887
  Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by
    Operating Activities:
      Depreciation and Amortization                                                              -                             -
      Non Cash Consulting and Services Paid by Stock I
      ssue                                                                                       -                        46,655
      (Increase) Decrease in Accounts Payable                                                4,968                      (118,903)
      (Increase) Decrease in Accrued Expenses                                               37,717                        55,729
                                                                       ----------------------------  ----------------------------
           Net Cash Provided (Used) by Operating
      Activities                                                       $                  (240,786)  $                   383,368
                                                                       ----------------------------  ----------------------------

Cash Flows from Investing Activities:
-------------------------------------

  Assets Disposed                                                                                -                        17,415
  Oil & Gas Properties                                                                     (31,107)                            -

           Net Cash Provided (Used) by Investing Activities            $                   (31,107)  $                    17,415


Cash Flows from Financing Activities:
-------------------------------------

  Increase in Short-Term Debt                                                                9,741                         1,880
  Increase in Paid  in capital                                                             204,116                             -
  Common Stock                                                                              54,596                      (401,500)
                                                                       ----------------------------  ----------------------------
           Net Cash Provided (Used) by Financing Activities            $                   268,453   $                  (399,620)
                                                                       ----------------------------  ----------------------------
Net Increase (Decrease) in Cash                                        $                    (3,440)  $                     1,163

Cash, Beginning of period                                                                    5,470                         1,724
                                                                       ----------------------------  ----------------------------
Cash, End of period                                                    $                     2,030   $                     2,887
                                                                       ============================  ============================
Supplemental Disclosure of Cash Flow Information
  Cash Paid During the Period for:
    Interest                                                           $                         -   $                         -
                                                                       ============================  ============================
    Income Taxes                                                       $                         -   $                         -
                                                                       ============================  ============================
</TABLE>


                                      F-5
<PAGE>
                      CONSOLIDATED MEDICAL MANAGEMENT, INC.

         NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

                           ___________________________


NOTE 1- BASIS OF PRESENTATION

GENERAL

The  consolidated  unaudited  interim  financial statements of the Company as of
September  30,  2002 and for the three and nine months ended September 30, 2002,
included  herein have been prepared in accordance with the instructions for Form
10QSB  under  the Securities Exchange Act of 1934, as amended, and Article 10 of
Regulation  S-X  under  the Securities Act of 1933, as amended. The December 31,
2001  Consolidated  Balance Sheet was derived from audited financial statements,
but  does  not include all disclosures required by generally accepted accounting
principles.  Certain  information  and  note  disclosures  normally  included in
financial  statements  prepared in accordance with generally accepted accounting
principles have been condensed or omitted pursuant to such rules and regulations
relating  to  interim  consolidated  financial  statements.

In  the  opinion  of management, the accompanying consolidated unaudited interim
financial  statements  reflect  all  adjustments,  consisting  only  of  normal
recurring adjustments, necessary to present fairly the financial position of the
Company at September 30, 2002, and the results of their operations for the three
and  nine months ended September 30, 2002 and 2001, and their cash flows for the
three  and  nine  months  ended  September  30,  2002  and  2001.

The results of operations for such periods are not necessarily indicative of
results expected for the full year or for any future period. These financial
statements should be read in conjunction with the audited consolidated financial
statements as of December 31, 2001and related notes included in the Company's
Form 10-KSB filed with the Securities and Exchange Commission

ORGANIZATION

The Company was incorporated under the laws of the State of Montana on August
13, 1981.  The Company ceased its mining operations in 1985, and discontinued
all business operations in 1990.  In August of 2001, the Company decided to
refocus on the oil and gas industry and entered into several Letters of Intent
only one of which survived the due diligence process.  The Company has signed a
letter of intent to acquire revenue-producing properties in Runnels County,
Texas.  CMMI has signed a farm-out agreement covering the 640-acre lease and are
currently in negotiations to acquire an additional 2400 acres from the same
operator. Subject to obtaining financing, CMMI could drill between 40-60
locations over the next 12-24 months on the 640-acre farm-out.


                                       F-6
<PAGE>
                      CONSOLIDATED MEDICAL MANAGEMENT, INC.

         NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

                           ___________________________


NOTE 2  -  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES ACCOUNTING METHOD

Accounting  policies of the Company conform to the generally accepted accounting
principles  and  reflect  practices  appropriate  to  the  industry  in which it
operates.  The  significant  policies  are  summarized  below.

     -    STOCK  SUBSCRIPTION  RECEIVABLES

     The  Company,  through an S-8 offering, grants options and stock to several
     individuals  for  stock.  As  of  September 30, 2002 and December 31, 2001,
     there  was  $  554,839 and $396,003 owed to the Company for stock purchased
     through  the  S-8  stock  program.

     -    PROPERTY,  EQUIPMENT  AND  DEPRECIATION

     Expenditures  for  property,  plant  and  equipment  are  recorded at cost.
     Renewals  and  improvements, which extend the economic life of such assets,
     are  capitalized.  Expenditures for maintenance, repairs and other renewals
     are  charged  to  expense. For major dispositions, the cost and accumulated
     depreciation are removed from the accounts and any gain or loss is included
     in  the  results of operations. During the year 2001, the Company abandoned
     the remaining assets relating to the healthcare operations in the amount of
     $17,415.  During  the  quarter  ended  September 30, 2002, the Company paid
     $31,107  for drilling cost that is being capitalized per the "full costing"
     accounting  method  for  oil  &  gas  investments.

     -    CASH  FLOWS  AND  CONCENTRATION  OF  CREDIT  RISK

     Cash  consists  principally  of  demand deposits at commercial banks. These
     balances,  as  reflected  in the bank's records, are insured by the Federal
     Deposit  Insurance  Corporation  up  to  $100,000. At December 31, 2001 and
     September  30,  2002,  the  Company's  deposits  did not exceed the insured
     limits.


                                      F-7

<PAGE>
                      CONSOLIDATED MEDICAL MANAGEMENT, INC.

         NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

                           ___________________________


EARNINGS PER COMMON SHARE

The  Company adopted Financial Accounting Standards  (SFAS) No.  128,  "Earnings
Per Share," which simplifies the computation of earnings per share requiring the
restatement  of  all  prior  periods.

Basic  earnings  per  share  are  computed  on the basis of the weighted average
number  of  common  shares  outstanding  during  each  year.

Diluted  earnings  per  share  are computed on the basis of the weighted average
number  of  common  shares  and  dilutive  securities  outstanding.  Dilutive
securities  having  an  anti-dilutive  effect  on diluted earnings per share are
excluded  from  the  calculation.  The  Company  does  not  have  any  dilutive
securities  as  of  September  30,  2002.


NOTE 3  - CONVERTIBLE DEBENTURES AND NOTES PAYABLE

The Company issued convertible debentures in 1998 that are subordinated to bank
debt and secured leases.  The debentures are otherwise unsecured but are given a
preference over unsecured debt. The debentures include interest at fifteen (15%)
percent, interest is payable in monthly installments.  Each debenture has a
conversion right for each holder to convert the debenture principal to shares of
the Company's common stock at the greater of $2.50 per share or ninety (90%)
percent of the bid price, whichever is greater on the date of conversion.
Accrued interest and any principal amount not converted to shares of stock will
be paid in cash at conversion.  The debentures are due one year from date of
issue. All debentures issued in 1998 were due in 1999, and they are in default
as of September 30, 2002.

The Company issued convertible promissory notes payable in 1998.  The notes are
unsecured and include interest at ten (10%) percent, interest is payable in
monthly installments.  Each note has a conversion right for each holder to
convert the note's unpaid principal to shares of the Company's common stock
based on $2.50 per share, or a total of 90,000 at the note holder's discretion.
Accrued interest and any principal amount not converted to shares of stock will
be paid in cash at conversion. As of December 31, the company had issued and
outstanding $325,000 in debentures.  The notes were due July 31, 1999, and they
are in default as of September 30 2002.

The Company has entered into an agreement with Spectrum Financial, Inc.
("Spectrum") whereby Spectrum will exchange shares it owns with the debenture
holder upon exercise of the debenture's conversion option, in satisfaction of
the Company's obligations under the conversion provisions.


                                       F-8
<PAGE>
                      CONSOLIDATED MEDICAL MANAGEMENT, INC.

         NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

                           ___________________________


In exchange, Spectrum will then receive an unsecured note payable from the
Company (see Note 7) for the face amount of the debenture surrendered. During
the year ended December 31, 1998, Spectrum exchanged a total of 14,000 of its
shares in connection with this agreement and received five notes payable from
the Company totaling $35,000.


     Total Convertible Debentures and Notes Payable     $       465,000
     Less: Current Portion                                     (465,000)
                                                        ----------------
     Long-Term Portion                                  $            -0
                                                        ================


NOTE  4  -  COMMON  AND  PREFERRED  STOCK

COMMON STOCK
------------

The Company's common stock is $0.001 par value, there are 50,000,000 shares
authorized as of as of December 31, 2001 and September 30, 2002, the Company had
13,587,293 and 17,187,293 shares issued and outstanding, respectively. During
the quarter ended September 30, 2002, the Company sold 3,050,000 shares of its
common stock for $51,000 in cash.

PREFERRED STOCK
---------------

In 1998, the Company amended its articles to authorize Preferred Stock.  There
are 20,000,000 shares authorized with a par value of $ 0.001.  The shares are
non-voting and non-redeemable by the Company.  The Company further designated
two series of its Preferred Stock:  "Series 'A' $12.50 Preferred Stock" with
2,159,193 shares of the total shares authorized and "Series 'A' $8.00 Preferred
Stock," with the number of authorized shares set at 1,079,957 shares.  As of
September 30, 2002 and December 31, 2001 there are no shares issued and
outstanding.

DIVIDENDS
---------

Dividends are non-cumulative, however, the holders of such series, in preference
to the holders of any common stock, shall be entitled to receive, as and when
declared payable by the Board of Directors from funds legally available for the
payment thereof, dividends in lawful money of the United States of America at
the rate per annum fixed and determined as herein authorized for the shares of
such series, but no more, payable quarterly on the last days of March, June,


                                       F-9
<PAGE>
                      CONSOLIDATED MEDICAL MANAGEMENT, INC.

         NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

                           ___________________________


September, and December in each year with respect to the quarterly period ending
on the day prior to each such  respective dividend payment date.  In no event
shall the holders of either series receive dividends of more than percent (1%)
in any fiscal year.  Each share of both series shall rank on parity with each
other share of preferred stock, irrespective of series, with respect to
dividends at the respective fixed or maximum rates for such series.

CONVERSION PROVISIONS
---------------------

Any holder of either series may convert any or all of such shares into shares of
common stock of the Company at any time. Said shares shall be convertible at a
rate equal to three (3) shares of common stock of the Company for each one (1)
share of Series "A" of $ 12.50 Preferred Stock.


  The Series "A" $12.50 Preferred Stock shall be convertible, in whole or in
part, at any time after the common stock of the Company shall maintain an
average bid price per share of at least $12.50 for ten (10) consecutive trading
days.

Series "A" $8.00 Preferred Stock shall be convertible at a rate equal to three
(3) shares of common stock of the Company for each one (1) share of Series "A"
$8.00 Preferred Stock.  The Series "A" $8.00 Preferred Stock shall be
convertible, in whole or in part, at any time after the common stock of the
Company shall maintain an average bid price per share of at least $8.00 for ten
(10) consecutive trading days.

The preferential amount payable with respect to shares of either Series of
Preferred Stock in the event of voluntary or involuntary liquidation,
dissolution, or winding-up, shall be an amount equal to $5.00 per share,  plus
the amount of any dividends declared and unpaid thereon.

NOTE 5 - COMMITMENT AND CONTINGENCIES

The Company has not recognized any commitments or contingencies at this time.

The Company's financial statements are prepared using generally accepted
accounting principles applicable to a going concern, which contemplates the
realization of assets and liquidation of liabilities in the normal course of
business. However, the Company does not have significant cash or other material
assets, nor does it have an established source of revenues sufficient to cover
its operating costs that raises substantial doubt about its ability to continue
as a going concern. The stockholders/officers and or directors have committed to
advancing operating costs of the Company interest free.



                                      F-10
<PAGE>
ITEM 2.  MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS.

The  following  discussion  should  be  read  in  conjunction with our unaudited
consolidated  interim financial statements and related notes thereto included in
this  quarterly  report and in our audited consolidated financial statements and
Management's  Discussion  and  Analysis  of  Financial  Condition and Results of
Operations ("MD&A") contained in our Form 10-KSB for the year ended December 31,
2001.  Certain  statements in the following MD&A are forward looking statements.
Words  such as "expects", "anticipates", "estimates" and similar expressions are
intended  to identify forward looking statements. Such statements are subject to
risks  and  uncertainties  that  could cause actual results to differ materially
from  those  projected.

GENERAL

Consolidated  Medical Management, Inc. ("CMMI"), was incorporated under the laws
of  the  State  of Montana on August 13, 1981 under the name Golden Maple Mining
and Leaching Company, Inc. On October 12, 2001, an Article of Amendment for Name
Change  to  Consolidated  Minerals  Management, Inc. was filed with the state of
Montana. CMMI's address is 7500 San Felipe, Suite 600, Houston, Texas 77063.

The  Company  is actively pursuing acquisitions and strategic investments in the
energy  industry. CMMI has secured funding that enabled the Company to drill two
Nacatoch  wells  in  Caddo  Parrish,  Louisiana.   CMMI  has  signed  a farm-out
agreement  covering  the  640-acre  lease  and  are currently in negotiations to
acquire  an  additional 2,400 acres from the same operator. Subject to obtaining
financing,  CMMI  could drill between 40-60 locations over the next 12-24 months
on  the  640-acre  farm-out.

However,  CMMI  is still in a development stage and will continue to incur costs
as  the  Company  evaluates  energy  prospects  prior  to investing in them. The
Company  has  relied  on  key  stockholders and officers to bear the substantial
costs  that  are involved in positioning CMMI to commence commercial operations.
We  expect  to continue to incur losses and face cash flow problems for a period
that  could  extend  for  several  years.

We believe that we will need to raise cash of at least $20,000 to continue our
operations through the end of 2002. The Company was successful in raising
$51,000 in the third quarter of 2002 through private placements; however,
additional capital will be required for the company to continue operations.

Since the Company has only limited financial resources, it may be difficult to
find good opportunities. There can be no assurance that the Company will be able
to identify and acquire any business opportunity based on management's business
judgment. The activities of the Company are subject to several significant risks
which arise primarily as a result of the fact that the Company has no specific
business and may acquire or participate in a business opportunity based on the
decision of management which potentially could act without consent, vote or
approval of the Company's shareholders. The risks faced by the Company are
further increased as a result of its lack of resources and its inability to
provide a prospective business opportunity with significant capital.


<PAGE>
COMPARISON OF QUARTER ENDED SEPTEMBER 30, 2001 TO QUARTER ENDED SEPTEMBER 30,
2002.

For the quarter ended September 30, 2002, our net loss was $(30,359) as compared
to  $(64,227) for the quarter ended September 30, 2001.  The decrease is related
to  a  decrease  in consulting costs since the company had determined to proceed
with  the  lease  acquisition  and  drilling  on  the 640-acre farm-out in Caddo
Parrish,  Louisiana.

COMPARISON  OF  NINE  MONTHS  ENDED  SEPTEMBER  30,  2001  TO  NINE MONTHS ENDED
SEPTEMBER  30,  2002.

For  the  nine  months  ended September 30, 2002, our net loss was $(283,471) as
compared  to  $(399,887)  for  the  nine  months  ended September 30, 2001.  The
decrease  is related to the outsourcing of most functions and the elimination of
all  non-essential  personnel.  Additionally,  the  officers  and directors have
agreed  to  defer  their  salaries  until  the  revenue  is  sufficient.

LIQUIDITY AND CAPITAL RESOURCES

During the year ended December 31, 2001, we experienced negative financial
results that have continued during the three months ended September 30, 2002 as
follows:
                                        THREE MONTHS          YEAR
                                           ENDED              ENDED
                                        SEPTEMBER 31,      DECEMBER 31,
                                           2002               2001
                                       --------------      -------------
    Net loss                           $     (30,359)      $  (167,551)*

    Accumulated deficit                   (4,298,785)       (4,014,314)


* The net loss for the three months ended September 31, 2001 was $64,227.

In addition to its negative financial results, we have significant accrued
liabilities, accounts payable and obligation to stockholders for expenses that
they have paid on behalf of our Company.

As a development stage company, CMMI has not generated any revenue and has been
dependent on debt and equity raised from individual investors to sustain its
operations. During the three months ended September 30, 2002, the Company
incurred a net loss of $(30,359) compared to net loss of $(64,227) for the three
months ended September 30, 2001. At September 30, 2002 the Company had negative
working capital of $(4,298,785). These factors raise substantial doubt about the
Company's ability to continue as a going concern.

The Company entered into private placement transactions in the third quarter of
2002 and raised $51,000.  The Company is currently considering a public sale or
private placement of its common stock if an active trading market for its
existing outstanding shares can be established. The Company is attempting to
finalize an energy acquisition which would be revenue producing.  The Company is
in discussions to raise the required funding. However, such sources of funding
may be unavailable. The Company's long-term viability as a going concern is
dependent on certain key factors as follows:


<PAGE>
-    The Company's ability to obtain adequate sources of funding to continue the
     implementation of its business strategy. Sources of funding may not be
     available on terms that are acceptable to the Company and existing
     stockholders, or may include terms that will result in substantial dilution
     to existing stockholders.

-    The ability of the Company to find suitable energy prospects to establish a
     revenue base.

-    The ability of the Company to ultimately achieve adequate profitability and
     strong operating cash flows to sustain its operations

-    The ability to obtain adequate sources of funding to continue the
     implementation of our strategic plan.

As a result of the issues facing the Company, the Company's independent
accountant included an emphasis paragraph in the report for the quarter ended
September 30, 2002 that addresses the substantial doubt as to the Company's
ability to continue as a going concern.


FORWARD-LOOKING INFORMATION - GENERAL

The statements contained herein and other information contained in this report
may be based, in part, on management's estimates, projections, plans and
judgments. These forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially from
historical results or those anticipated. In this report, the words
"anticipates", "believes", "expects", "intends", "future", "plans", "targets"
and similar expressions identify forward-looking statements. Readers are
cautioned to not place undue reliance on the forward-looking statements
contained herein. Additionally, these statements are based on certain
assumptions that may prove to be erroneous and are subject to certain risks
including, but not limited to, the Company's dependence on limited cash
resources, its dependence on certain key personnel within the Company, and its
ability to raise additional capital.  The Company's ability to generate
long-term value for the common stockholder is dependent upon the acquisition of
profitable energy prospects. There are many companies participating in the oil
and gas industry, many with resources greater than the Company. Greater
competition for profitable operations can increase prices and make it more
difficult to acquire assets at reasonable multiples of cash flow.  The Company
believes that it will be able to compete in this environment and will be able to
find attractive investments; however, it is not possible to predict competition
or the effect this will have on the Company's operations. The Company's
operations are also significantly affected by factors, which are outside the
control of the Company, including the prices of oil and natural gas,
environmental and governmental regulations. Accordingly, actual results may
differ, possibly materially, from the predictions contained herein.


ITEM 3.  EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES.

Timothy G. Byrd, Sr., our Chief Executive Officer and Acting Chief Accounting
Officer, has concluded that our disclosure controls and procedures are
appropriate and effective.   He has evaluated these controls and procedures as
of a date within 90 days of the filing date of this report on Form 10-QSB.
There were no significant changes in our internal controls or in other factors
that could significantly affect these controls subsequent to the date of their
evaluation, including any corrective actions with regard to significant
deficiencies and material weaknesses.


<PAGE>
                                     PART II

Pursuant to the Instructions on Part II of the Form 10-QSB, Items 1, 3, and 5
are omitted.

ITEM 2.  CHANGES IN SECURITIES

The following information sets forth certain information for all securities the
Company issued from July 1, 2002 through September 30, 2002, in transactions
without registration under the Act.  There were no underwriters in any of these
transactions, nor were any sales commissions paid thereon. The securities were
issued pursuant to Section 4(2) of the Act.

A total of 3,050,000 shares were issued for private placement transactions to
seven investors for cash proceeds of $51,000.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

None

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

None

                                   SIGNATURES

Pursuant to the requirements of section 13 or 15(d) of the Securities Exchange
Act of 1934, the undersigned has duly caused this Form 10-QSB to be signed on
its behalf by the undersigned, there unto duly authorized, in the City of
Houston, Texas, on November 19, 2002.

CONSOLIDATED MEDICAL MANAGEMENT, INC.

By:  /s/ Timothy G. Byrd, Sr.
---------------------------------------------
     Timothy G. Byrd, Sr.
     Chief Executive Officer, Acting Chief Accounting Officer, and Director


<PAGE>
Certifications

I, Timothy G. Byrd, Sr., certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Consolidated Medical
Management, Inc.;
2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;
3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;
4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:
a) designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the
period in which this quarterly report is being prepared;
b) evaluated the effectiveness of the registrant's disclosure controls and
procedures as of a date within 90 days prior to the filing date of this
quarterly report (the "Evaluation Date"); and
c) presented in this quarterly report our conclusions about the effectiveness of
the disclosure controls and procedures based on our evaluation as of the
Evaluation Date;
5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent
functions):
a) all significant deficiencies in the design or operation of internal controls
which could adversely affect the registrant's ability to record, process,
summarize and report financial data and have identified for the registrant's
auditors any material weaknesses in internal controls; and
b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls; and
6. The registrant's other certifying officers and I have indicated in this
quarterly report whether there were significant changes in internal controls or
in other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.

Date: November 19, 2002
/s/Timothy G. Byrd, Sr.
-----------------------
Timothy G. Byrd, Sr.
Chief Executive Officer


<PAGE>
I, Timothy G. Byrd, Sr., certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Consolidated Medical
Management, Inc.;
2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;
3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;
4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:
a) designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the
period in which this quarterly report is being prepared;
b) evaluated the effectiveness of the registrant's disclosure controls and
procedures as of a date within 90 days prior to the filing date of this
quarterly report (the "Evaluation Date"); and
c) presented in this quarterly report our conclusions about the effectiveness of
the disclosure controls and procedures based on our evaluation as of the
Evaluation Date;
5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent
functions):
a) all significant deficiencies in the design or operation of internal controls
which could adversely affect the registrant's ability to record, process,
summarize and report financial data and have identified for the registrant's
auditors any material weaknesses in internal controls; and
b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls; and
6. The registrant's other certifying officers and I have indicated in this
quarterly report whether there were significant changes in internal controls or
in other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.

Date: November 19, 2002
/s/Timothy G. Byrd, Sr.
-----------------------
Timothy G. Byrd, Sr.
Acting Chief Accounting Officer


<PAGE>
Certification of Chief Executive Officer and Acting Chief Accounting Officer of
-------------------------------------------------------------------------------
Consolidated Medical Management, Inc. pursuant to Section 906 of the
--------------------------------------------------------------------
Sarbanes-Oxley Act of 1992 and Section 1350 of 18 U.S.C. 63.
-----------------------------------------------------------

I, Timothy G. Byrd, Sr., the Chief Executive Officer and Acting Chief Accounting
Officer of Consolidated Medical Management, Inc. hereby certify that to my
knowledge, Consolidated Medical Management's periodic report on Form 10-QSB for
the period ended September 30, 2002, fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that
information contained in the periodic report on Form 10-QSB and the financial
statements contained therein fairly presents, in all material respects, the
financial condition and results of the operations of Consolidated Medical
Management, Inc.

Date:  November 19, 2002                  /s/ Timothy G. Byrd, Sr.
                                          ------------------------
                                          Timothy G. Byrd, Sr.,
                                          Chief Executive Officer
                                          Consolidated Medical Management, Inc.




Certification of Chief Executive Officer and Acting Chief Accounting Officer of
-------------------------------------------------------------------------------
Consolidated Medical Management, Inc. pursuant to Section 906 of the
--------------------------------------------------------------------
Sarbanes-Oxley Act of 1992 and Section 1350 of 18 U.S.C. 63.
-----------------------------------------------------------

I, Timothy G. Byrd, Sr., the Chief Executive Officer and Acting Chief Accounting
Officer of Consolidated Medical Management, Inc. hereby certify that to my
knowledge, Consolidated Medical Management's periodic report on Form 10-QSB for
the period ended September 30, 2002, fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that
information contained in the periodic report on Form 10-QSB and the financial
statements contained therein fairly presents, in all material respects, the
financial condition and results of the operations of Consolidated Medical
Management, Inc.

Date:  November 19, 2002                  /s/ Timothy G. Byrd, Sr.
                                          ------------------------
                                          Timothy G. Byrd, Sr.,
                                          Chief Executive Officer
                                          Consolidated Medical Management, Inc.


<PAGE>